Oncolytics Biotech (ONCY) vs Verrica Pharmaceuticals (VRCA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Verrica Pharmaceuticals (VRCA) has outperformed Oncolytics Biotech (ONCY) over the past year, losing 10.2% versus a loss of 55.9%. Over five years, ONCY leads with a -73.2% price change compared with -96.9% for VRCA. Oncolytics Biotech is the larger company by market cap ($73.4 million vs $71.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCY | VRCA |
|---|---|---|
| Share price | $0.56 | $4.15 |
| Market cap | $73.43M | $71.29M |
| 1-day change | -6.11% | +0.24% |
| YTD return | -31.52% | -50.18% |
| 1-year return | -55.87% | -10.20% |
| 5-year return | -73.16% | -96.90% |
| EPS (TTM) | $-0.35 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.32 | $9.82 |
| 52-week low | $0.5418 | $3.28 |
| Distance from 52-week high | -57.58% | -57.74% |
| Average volume | 1.10M | 62.53K |
| Shares outstanding | 131.12M | 17.18M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VRCA has outperformed ONCY by 45.7 percentage points over the past year.
ONCY vs VRCA FAQ
Which is bigger, Oncolytics Biotech or Verrica Pharmaceuticals?
Oncolytics Biotech (ONCY) is larger, with a market capitalization of $73.43M compared with $71.29M for Verrica Pharmaceuticals (VRCA).
Which stock has performed better over the past year, ONCY or VRCA?
VRCA returned -10.20% over the past 12 months, compared with -55.87% for ONCY (price return, excluding dividends). Past performance does not predict future results.
Are Oncolytics Biotech and Verrica Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.